Hepatic Encephalopathy Management
On this page
Direct answer
Search the precipitant before reaching for the lactulose: infection heads the list, followed by gastrointestinal bleeding, constipation, dehydration and over-diuresis, electrolyte disturbance (hypokalaemia driving systemic alkalosis and ammonia entry to the brain), sedatives, dietary protein surges, TIPS, portal vein thrombosis and unsuspected hepatocellular carcinoma — because correcting the trigger does more for coma resolution than any cathartic. Lactulose remains first-line: 25 mL every 1–2 hours until two to three soft stools are achieved, then titrated to 2–3 soft stools daily; in overt encephalopathy, polyethylene glycol–based lavage clears ammonia faster in the first day. Rifaximin 550 mg twice daily is the add-on that prevents recurrence (halving episodes over six months in the pivotal trial) and continues alongside, not instead of, lactulose. Protein is never restricted — 1.2–1.5 g/kg daily with a late-evening snack — and grade III–IV disease is an airway and intensive-care problem.
What you must remember
- Classification: type A (acute liver failure), type B (portosystemic bypass without cirrhosis — TIPS, shunts, congenital), type C (cirrhosis with portal hypertension); covert disease (minimal plus grade I) needs psychometric (PHES) or critical flicker frequency testing, while overt disease runs the West Haven grades I–IV from sleep reversal and asterixis to coma.
- Asterixis and the exam: the flapping tremor of grade II–III disease, best elicited in extended dorsi-flexed wrists, alongside constructional apraxia (the five-pointed star) and disorientation — the three bedside signs an examiner asks you to demonstrate.
- Ammonia in its place: arterial ammonia correlates loosely with severity, supports the diagnosis when the picture is ambiguous, and falls with effective therapy — but grading and treatment decisions are clinical, and a "normal" ammonia never excludes encephalopathy.
- Lactulose mechanics and targets: a non-absorbed disaccharide fermented to organic acids, acidifying colonic contents and trapping ammonia as ammonium; titrate to 2–3 soft stools daily — more causes dehydration and worsens the encephalopathy it was meant to treat; rectal lactulose or PEG lavage when the patient cannot swallow safely.
- Rifaximin rule: 550 mg twice daily as add-on for prevention of recurrent overt episodes (about 58 per cent risk reduction over six months with lactulose in the trial data), continued long-term; minimal-absorption safety profile; L-ornithine L-aspartate (LOLA) lowers ammonia by enhancing urea synthesis and is widely used in Indian practice, with zinc repletion for deficient patients.
- Nutrition doctrine: 1.2–1.5 g/kg/day protein, 30–35 kcal/kg, with a late-evening snack to prevent overnight catabolism; long-standing protein restriction worsens sarcopenia and mortality; branched-chain amino acid supplements serve the protein-intolerant.
- Airway arithmetic: grade III (somnolence to semi-stupor) and grade IV (coma) need positioning, aspiration precautions and intubation for airway protection — with escalation of intracranial pressure monitoring and management concerns mainly in type A (acute liver failure) settings.
- Refractory and recurrent disease: recurrent overt encephalopathy despite lactulose-rifaximin therapy prompts a shunt hunt (TIPS reduction or occlusion for type B), large spontaneous portosystemic shunt embolisation in selected patients, and transplant evaluation because recurrent encephalopathy marks poor hepatic reserve.
- The driving-consultation and fall risk: covert encephalopathy impairs driving and daily function even when the clinic conversation seems normal — a documented counselling point and an exam-ready ethical answer.
A worked night-shift case
A 62-year-old with hepatitis C cirrhosis is brought in drowsy and combative, asterixis positive, sleeping days and awake nights. The search is immediate and ordered: blood cultures and urinalysis (the commonest precipitant), rectal examination and a check for melena, electrolytes (potassium 2.9 with alkalosis), creatinine, and a low threshold for a head CT when the neurological picture is focal or the course atypical. Lactulose 25 mL two-hourly by nasogastric tube until three soft stools, potassium corrected, no sedatives (a combative encephalopathic patient is restrained physically, not pharmacologically, if possible). Over 48 hours he clears. Before discharge: rifaximin 550 mg twice daily is added to the maintenance lactulose because this is his second episode, the family receives the protein doctrine (never restrict, late-evening snack), and the first outpatient visit books psychometric testing and a transplant-priority conversation. Had he arrived at grade III with a gag that failed, the same workup runs alongside an intensive-care airway.
Where students slip
Three errors recur. Sedating the agitated encephalopathic patient with benzodiazepines — deepening the coma while the precipitant goes unfound. Restricting protein on the outdated ammonia-phobia model — sarcopenia and mortality worsen. And stopping lactulose once rifaximin starts — rifaximin is an add-on, not a replacement; the pair is the maintenance answer. The Indian viva also probes LOLA's rationale (substrate for ornithine-cycle ammonia detoxification) and the reason arterial ammonia beats venous — respiratory gas exchange in the syringe falsely lowers venous values.
Frequently asked questions
Which precipitants are sought in every episode of hepatic encephalopathy?
Infection first, then gastrointestinal bleeding, constipation, dehydration or over-diuresis, hypokalaemia and alkalosis, sedatives, TIPS or shunt change, portal vein thrombosis and hepatocellular carcinoma.
How is lactulose dosed and titrated?
25 mL every 1–2 hours until two or three soft stools occur, then adjusted to a maintenance pattern of 2–3 soft stools daily; over-purging causes dehydration and paradoxical worsening.
What does rifaximin add and when?
Rifaximin 550 mg twice daily with continued lactulose reduces recurrent overt encephalopathy by about half over six months and is started after the first recurrence.
Should dietary protein be restricted in encephalopathy?
No — 1.2–1.5 g/kg daily with a late-evening snack is the standard; restriction worsens sarcopenia and outcomes, with branched-chain amino acids reserved for genuine intolerance.
How are grade III–IV patients managed?
Airway protection with intubation, intensive-care monitoring, lactulose by tube or rectally (or PEG lavage), precipitant correction — with intracranial pressure management principally a type A acute liver failure concern.